Compare · CHE vs REUN
CHE vs REUN
Side-by-side comparison of Chemed Corp (CHE) and Reunion Neuroscience Inc. (REUN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and REUN operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE carries a market cap of $7.14B.
- CHE has hit the wire 12 times in the past 4 weeks while REUN has been quiet.
- CHE has more recent analyst coverage (8 ratings vs 0 for REUN).
- Company
- Chemed Corp
- Reunion Neuroscience Inc.
- Price
- -
- -
- Market cap
- $7.14B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 12
- 0
- Recent ratings
- 8
- 0
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Latest CHE
- Executive vice president Lee Spencer S sold $494,196 worth of Capital Stock (920 units at $537.17), decreasing direct ownership by 6% to 13,931 units (SEC Form 4)
- Chemed Corporation to Present at the UBS 2026 Global Healthcare Conference
- SEC Form 10-Q filed by Chemed Corp
- Chemed upgraded by Jefferies with a new price target
- SEC Form 8-K filed by Chemed Corp
- Chemed Reports Third-Quarter 2026 Results
- SEC Form 4 filed by Chemed Corp
- SEC Form 4 filed by Chemed Corp
- SEC Form 4 filed by Chemed Corp
- SEC Form 4 filed by Chemed Corp
Latest REUN
- SEC Form 15-12G filed by Reunion Neuroscience Inc.
- Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
- Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
- SEC Form 6-K filed by Reunion Neuroscience Inc.
- SEC Form SC 13D/A filed by Reunion Neuroscience Inc. (Amendment)
- SEC Form F-10POS filed by Reunion Neuroscience Inc.
- SEC Form S-8 POS filed by Reunion Neuroscience Inc.
- SEC Form S-8 POS filed by Reunion Neuroscience Inc.
- SEC Form 25-NSE filed by Reunion Neuroscience Inc.
- Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement